Extendicare Inc. (TSE:EXE – Get Free Report) declared a monthly dividend on Monday, September 16th, Zacks reports. Investors of record on Monday, September 30th will be given a dividend of 0.04 per share on Tuesday, October 15th. This represents a $0.48 annualized dividend and a yield of 5.17%. The ex-dividend date of this dividend is Monday, September 30th.
Extendicare Stock Performance
Shares of Extendicare stock opened at C$9.28 on Tuesday. The stock has a market capitalization of C$774.60 million, a price-to-earnings ratio of 13.65 and a beta of 1.26. The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. The business has a 50-day moving average of C$8.07 and a 200 day moving average of C$7.62. Extendicare has a 12 month low of C$5.75 and a 12 month high of C$9.48.
Extendicare (TSE:EXE – Get Free Report) last posted its quarterly earnings data on Monday, August 12th. The company reported C$0.29 EPS for the quarter. The business had revenue of C$348.48 million during the quarter, compared to analyst estimates of C$360.20 million. Extendicare had a net margin of 4.28% and a return on equity of 60.00%.
Analyst Upgrades and Downgrades
Get Our Latest Report on Extendicare
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- Earnings Per Share Calculator: How to Calculate EPS
- Market Got It Wrong—Why Progress Software Deserves a Second Look
- What Are Dividend Challengers?
- PENN Entertainment Eyes ESPN BET to Score Big in 2024 NFL Season
- Most Volatile Stocks, What Investors Need to Know
- Don’t Miss Out: NETGEAR’s Turnaround Signals Big Potential
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.